Start Making Profits Now With ANF, VRX, JNJ and GLW
May 25, 2013
When Fortune named Genentech the Best Company To Work For in 2006, Betsy Morris’s profile of the “low-key, high-tech biotech” touched on the free cappuccino, wacky Halloween parties (including current... Read More
category
NYSE:VRX
from Forbes Real Time
Valeant May Buy Bausch & Lomb
May 24, 2013
Flat Close Over Fed Stimulus Plan Concerns
May 24, 2013
The markets closed flat with the Dow adding 8 points to 15,303 over concerns that the Federal Reserve would taper down its bond buying program. Nasdaq held steady at 3459. Read More
category
Market News
* TSX ends up 9.13 points, or 0.07 percent, to 12,667.22 * Index gains 0.4 percent in shortened week * Valeant shares surge after reports of $9 billion Bausch & Lomb bid * Manitoba Telecom climbs after... Read More
category
companyNews
Bausch & Lomb's Ista pleads guilty over kickbacks
May 24, 2013
Ista Pharmaceuticals Inc pleaded guilty on Friday to charges it used kickbacks and improper marketing to boost sales of a drug meant to treat eye pain and agreed to pay $33. Read More
from FOX News
category
companyNews
VRX: Summary for Valeant Pharmaceuticals Intl Inc.
May 24, 2013
Sellers were in the market again Friday but the selling pressure wasn't intense. The Nasdaq and S&P 500 lost 0.3% each. The Dow Jones industrial average eased 0.2%. Volume was very light ahead of the... Read More
category
Intraday Updates
NEW YORK, May 24 (Reuters) - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, a... Read More
category
companyNews
Midday Movers: VRX, FNMA, ABX & More
May 24, 2013
category
Barrick Gold Corporation
,
Valeant Pharmaceuticals International
,
Intuitive Surgical Inc/
, and 1 more.
from CNBC.com News
Valeant Pharmaceuticals (NYSE: VRX) instantly jumps to a new 52-week high of $87.49 per share after it is announced that contact lens and eye care product giant Bausch & Lomb is close to selling itself... Read More
from Bio-Wire.Com
NEW YORK, May 24 (Reuters) - Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch & Lomb from private equity owner Warburg Pincus LLC for about $9... Read More
category
companyNews
NEW YORK (AVAFIN) -- Financial institutions traded 13 block trades on shares of Valeant ... Read More
from AVAFIN
from PR Newswire
Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
May 20, 2013
from PR Newswire
It was a muted start for U.S. equities when the stock market today (Monday) opened. But by mid-day, the bulls were back and benchmarks marched higher. Just before noon, the Dow Jones Industrial Average... Read More
from Money Morning
Pharma M&A – Actavis to Acquire Warner Chilcott
May 20, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here